This clinical trial is for men and women ages 18 and older with follicular lymphoma with detectable BCL2 translocation or mantle cell lymphoma with presence of cyclin D1 overexpression. The objective of this study is to assess the possibility of treating follicular lymphoma and mantle cell lymphoma patients with ribavirin and using cell free DNA (cfDNA) for BCL2-t and cyclin D1 extracted from peripheral blood to measure treatment effect.
...
